Premarket Decliner
OKUR Onkure Therapeutics - Class A4.59+0.59+14.8%
Premarket:3.98-0.61 (-13.3%)
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Ka Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
Globe NewswireFri, 27-Mar 8:00 AM
